Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma
- PMID: 32473636
- PMCID: PMC7261378
- DOI: 10.1186/s12957-020-01877-w
Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma
Abstract
Purpose: This study aims to identify predictive local recurrence risk factors and site-specific local recurrence pattern of upper tract urothelial carcinoma (UTUC) with different primary tumor locations.
Methods: Three hundred and eighty-nine UTUC patients with radical nephroureterectomy were included in this study. Univariate and multivariate Cox proportional hazards regressions were performed to measure the risk of local recurrence. We also mapped the position of local recurrence sites stratified by primary tumor locations.
Results: A total of 73 patients (18.7%) developed local recurrence within a median follow-up of 41 months (range, 3-80 months). For patients with local recurrence, the median interval of local recurrence was 9 months. Ureter tumor, multifocality, T stage, G grade, lymph node metastasis (LNM), lymph node dissection (LND), and lymph vascular invasion (LVI) were all significantly associated with increased local recurrence by univariable analyses (P < 0.05). Only multifocality, T3-4, G3, and LNM remained independent predictors of increased local recurrence by multivariable analyses. Adjuvant radiotherapy could reduce the local recurrence (HR = 0.177; 95% CI 0.064-0.493, P = 0.001). Patients with local recurrence had poorer cancer-specific survival (4-year cancer-specific survival rate 36 ± 7.5% vs 88.4 ± 2.2%, P = 0.000). We evaluated local recurrence pattern stratified by tumor locations. Para-aortic lymph node region was the most common recurrence area for all the patients. Left-sided UTUC had more than 70% recurrent lymph nodes in the left para-aortic region (LPA). For right-sided UTUC patients, recurrent para-aortic lymph nodes distributed in the LPA (33.3%), aortocaval (AC) (41.5%), and right paracaval (RPC) (25.2%) regions. Recurrence in the internal and external iliac regions was only found in the distal ureter group (P < 0.05). Renal pelvic fossa recurrence was only found in renal pelvic tumor (22.2%, P = 0.007). The ureter tumor bed recurrence rate was higher for ureter patients (P = 0.001).
Conclusions: Multifocality, T3-4, G3, and LNM are predictors of higher local recurrence rate of UTUC. Adjuvant radiotherapy can reduce local recurrence rate. Local recurrence patterns are different according to primary tumor locations.
Keywords: Local recurrence; Primary tumor location; Risk factor; Upper tract urothelial carcinoma.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Impact of Tumor Location on Local Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: Implications for Adjuvant Radiotherapy.Clin Genitourin Cancer. 2017 Apr;15(2):e199-e204. doi: 10.1016/j.clgc.2016.07.010. Epub 2016 Jul 21. Clin Genitourin Cancer. 2017. PMID: 27567188
-
Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.J Urol. 2015 Dec;194(6):1567-74. doi: 10.1016/j.juro.2015.06.077. Epub 2015 Jun 19. J Urol. 2015. PMID: 26094807 Free PMC article.
-
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.Eur J Surg Oncol. 2019 Jul;45(7):1238-1245. doi: 10.1016/j.ejso.2018.12.004. Epub 2018 Dec 11. Eur J Surg Oncol. 2019. PMID: 30563773
-
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.World J Urol. 2017 Mar;35(3):327-335. doi: 10.1007/s00345-016-1819-1. Epub 2016 Apr 4. World J Urol. 2017. PMID: 27043218 Review.
-
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.World J Urol. 2017 Mar;35(3):355-365. doi: 10.1007/s00345-016-1859-6. Epub 2016 May 27. World J Urol. 2017. PMID: 27233780 Free PMC article. Review.
Cited by
-
Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease.Cancers (Basel). 2023 Dec 20;16(1):44. doi: 10.3390/cancers16010044. Cancers (Basel). 2023. PMID: 38201472 Free PMC article. Review.
-
Surgical and oncological outcomes of robot-assisted versus laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: A single-center comparative analysis.Indian J Urol. 2023 Oct-Dec;39(4):285-291. doi: 10.4103/iju.iju_128_23. Epub 2023 Sep 29. Indian J Urol. 2023. PMID: 38077196 Free PMC article.
-
Postoperative adjuvant radiotherapy for patients with upper tract urothelial carcinoma (UTUC) who underwent kidney-sparing surgery (KSS): a single-center study.Radiat Oncol. 2023 Jul 18;18(1):120. doi: 10.1186/s13014-023-02303-7. Radiat Oncol. 2023. PMID: 37464353 Free PMC article.
-
Value of contrast-enhanced ultrasound in the differential diagnosis of ureteral tuberculosis from ureteral malignant tumour in women.Epidemiol Infect. 2023 Mar 15;151:e53. doi: 10.1017/S0950268823000419. Epidemiol Infect. 2023. PMID: 36919207 Free PMC article.
-
Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis.Curr Oncol. 2022 Dec 20;30(1):19-36. doi: 10.3390/curroncol30010002. Curr Oncol. 2022. PMID: 36661651 Free PMC article. Review.
References
-
- Genega Elizabeth M., Porter Christopher R. Urothelial Neoplasms of the Kidney and Ureter. Pathology Patterns Reviews. 2002;117(suppl_1):S36–S48. - PubMed
-
- Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer. 1999;85(6):1342–1344. - PubMed
-
- Yang MH, Chen KK, Yen CC, Wang WS, Chang YH, Huang WJ, Fan FS, Chiou TJ, Liu JH, Chen PM. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology. 2002;59(5):681–687. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
